@prefix nt: .
@prefix this: .
@prefix sub: .
@prefix drugbank: .
@prefix np: .
@prefix mondo: .
@prefix pav: .
@prefix infores: .
@prefix xsd: .
@prefix orcid: .
@prefix rdfs: .
@prefix pmid: .
@prefix ncit: .
@prefix rdf: .
@prefix biolink: .
@prefix prov: .
@prefix npx: .
sub:Head {
this: a np:Nanopublication;
np:hasAssertion sub:assertion;
np:hasProvenance sub:provenance;
np:hasPublicationInfo sub:pubInfo .
}
sub:assertion {
drugbank:DB00425 a biolink:Drug;
rdfs:label "Zolpidem";
biolink:category biolink:Drug .
mondo:0100081 a biolink:Disease;
rdfs:label "sleep disorder";
biolink:category biolink:Disease .
sub:association a biolink:ChemicalToDiseaseOrPhenotypicFeatureAssociation;
rdf:object mondo:0100081;
rdf:predicate biolink:treats;
rdf:subject drugbank:DB00425;
rdfs:label "Melatonin (97%), trazodone (81%), and quetiapine (73%) were rated by a majority of respondents as effective. Doxepin, zaleplon, tricyclic antidepressants, zolpidem, or lorazepam were rarely prescribed due to lack of evidence and/or concerns about adverse effects, long-term safety, suitability for youth, suicidality, and dependence/tolerance.";
biolink:aggregator_knowledge_source infores:knowledge-collaboratory;
biolink:category biolink:ChemicalToDiseaseOrPhenotypicFeatureAssociation;
biolink:has_population_context sub:context;
biolink:publications pmid:32175006;
biolink:relation ncit:C94303 .
sub:context a biolink:Cohort;
rdfs:label "Children and adolescents";
biolink:category biolink:Cohort;
biolink:has_phenotype mondo:0005371 .
}
sub:provenance {
sub:assertion prov:wasAttributedTo orcid:0000-0002-7641-6446 .
}
sub:pubInfo {
sub:sig npx:hasAlgorithm "RSA";
npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCR9fz0fKCdWOWC+pxhkQhEM/ppbdIYe5TLSdj+lJzSlv9mYBaPgrzVezSwwbmhlHBPDZa4/vHycU315BdmUGq+pXllp9+rWFfrb+kBJwhZjpG6BeyyXBsRFz4jmQVxl/ZYHilQTh/XalYzKkEAyTiEMPee4Kz61PaWOKH24CsnOQIDAQAB";
npx:hasSignature "GInc93G3xEVfL9Fa1ZOshRnbzeRAfVszrCacNFLYpdTLhJpnCcfjxdrUL0VxnwZrhbiOSPKQDqXpnxABsNDkCUoJhVAANUQsu4JNwU1520G8N6NHwtE5JcS18NbNdFiTzp8noYrMt3A/g4cBE4jksIsGTUS0xK1lMD7v43BXRzk=";
npx:hasSignatureTarget this: .
this: prov:generatedAtTime "2022-09-16T11:46:56.871307"^^xsd:dateTime;
prov:wasAttributedTo orcid:0000-0002-1501-1082;
nt:wasCreatedFromTemplate .
biolink: pav:version "2.3.0" .
}